Phibro Animal Health just received a new price target, marking a fresh chapter in how the stock is being framed by analysts and investors. This update reflects a shift in expectations around the ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common ...

TEANECK, N.J.--(BUSINESS WIRE)--(NASDAQ: PAHC) The Food and Drug Administration (FDA), through its Center for Veterinary Medicine (CVM), has taken two actions regarding Mecadox ® (carbadox), a drug ...

Animal health products manufacturer Phibro Animal Health (NASDAQ:PAHC) in Q1 CY2026, with sales flat year on year at $347.8 million. On the other hand, the company’s outlook for the full year was ...

JPMorgan upgraded Phibro Animal Health Corporation (NASDAQ:PAHC), citing strong execution following its $350 million acquisition of Zoetis' medicated feed additive and water-soluble product portfolio.

If you are wondering whether Phibro Animal Health's current share price lines up with its underlying worth, you are not alone ...

PAHC shares are up 90.9% this year, fueled by surging vaccine sales, new Brazil capacity and rapid growth across emerging ...

Phibro Animal Health Corp. entered into a definitive agreement to acquire Zoetis Inc.’s medicated feed additive product portfolio for $350 million. The New Jersey-based companies announced the ...

Phibro Animal Health PAHC has seen impressive momentum in the past year, with its shares soaring 82.8%. It has significantly outperformed the 9.6% rise of the industry and the S&P 500 Composite’s 26.7 ...